Insulin release kinetics were studied in perifused islets of Langerhans, isolated from mildly hyperglycaemic and from normoglycaemic spiny mice (Acomys cahirinus), a rodent predisposed to develop spontaneously non-ketotic diabetes. In both groups, insulin response to glucose (16.7 mmol/1) was delayed in comparison with that of rat islets, the release kinetics being analogous to that of human Type 2 (non-insulin-dependent) diabetes. Thirty min priming of the isolated Acomys islets with glucose (16.7 retool/l) resulted in potentiation of the insulin release to a second stimulation. The degree of potentiation decreased exponentially with the time interval between stimulations, showing a tl/2 of 18 min. Induction of potentiation by glucose was time-dependent, giving a maximal effect after 20 min of priming. In addition to overall amplification of the insulin response, printing with glucose accelerated markedly the initial release rates, correcting the dynamics of the response. We conclude that: (1) decreased and delayed insulin secretion is found in Acomys cahirinus before the development of hyperglycaemia; (2) induction of time-dependent potentiation in the islet by priming with glucose corrects the diabetic-type dynamics of insulin release; (3) therefore the deficient insulin release of Acomys is of a functional nature, the mechanism of potentiation bypassing the defect; (4) since insulin release in Acomys resembles that in prediabetic and diabetic man, similar conclusions might apply to the islet dysfunction in Type 2 diabetes.
Glucose intolerance and hyperglycaemia in Type 2 diabetes are the result of an inappropriate pancreatic response to changes in the blood glucose level, accompanied by some decrease in peripheral response to insulin [1] . The inappropriate pancreatic response is characterized by reduction in the sensitivity of fl cells to glucose and delay or absence of the acute insulin response [2] [3] [4] [5] [6] [7] . To elucidate the metabolic defect(s) of the/3 cells, suitable animal models for Type 2 diabetes are needed. The spiny mouse (Acomys cahirinus) is a semi-desert rodent which has been studied extensively as a model for Type 2 diabetes in man [8] [9] [10] [11] [12] [13] [14] [15] [16] . Bred in captivity, these animals demonstrate various degrees of glucose intolerance, become obese with age and develop hyperglycaemia. At all stages of glucose intolerance, whether obese or lean, bred in captivity or newly captured, the spiny mouse exhibits decreased insulin response to glucose stimulation, both in vivo and in vitro [10] [11] [12] [13] [14] 16] .
Studies in recent years demonstrated that apart from initiating immediate insulin release, glucose generates a time-dependent state of potentiation in the islets of Langerhans, which leads to the amplification of insulin secretion upon subsequent stimulation [17] [18] [19] [20] [21] [22] . The present study examines the effect of such glucose priming on insulin release in the islets of spiny mice and demonstrates that it corrects the diabetic pattern of insulin secretion.
Materials and methods
Islets of Langerhans were isolated by collagenase digestion (Serva Feinbiochemica, Heidelberg, FRG) [23] from non-fasted male rats (5-7 weeks old Sabra HUC strain) weighing 150-200g, and from adult hyperglycaemic or normoglycaemic Acomys cahirinus. All animals were bred and raised at the Hebrew University animal farm and maintained on free laboratory chow diet. Two groups of spiny mice, age 4-9 months, were used: the hyperglycaemic animals (n = 37) had a morning (non-fasting, prior to killing) mean plasma glucose of 9.2 + 0.7 mmol/1 compared with 5.6 + 0.2 mmol/1 in the normoglycaemic Acomys (n = 16). The mean morning plasma glucose level in the fed rats was 7.8 _+ 0.2 mmol/1 (n = 10).
The isolated islets were washed at 4 C in oxygen-saturated Hanks solution supplemented with glucose (5.5 mmol/l), and suspended at 4C in basal Krebs-Ringer-bicarbonate buffer containing glucose 3.3 mmol/1. Thirty to fifty islets were transferred into a perifusion chamber (70 l-tl) and perifused at 37 C at a flow rate of 1.0 ml/min Acomys and rat immunoreactive insulin levels were determined in the perifusate by radioimmunoassay [13] using 20% polyethylene glycol for separation of bound ligand from free hormone. Human insulin was used as reference standard for Acomys islets and rat insulin for rat islets. The reference insulins were obtained from Novo Research Institute, Bagsvaerd, Denmark. The minimal detectable dose in the insulin assay was 1-3 l.tU/ml, the intraassay C.V. was 5.7% and the interassay C.V. was 8.8%. Plasma glucose levels were determined by the glucose oxidase method using a Glucose Analyzer 2 (Beckman Instruments Co., Fullerton, California).
Results
Although Acomys islets appear larger in size than rat islets, there was no significant difference in their insulin content. Islet insulin content in 10 animals from each group (not used for perifusion) was 35 +6 ng/islet in rats; 25+7ng/islet in hyperglycaemic Acomys and 22 +_ 6 rig/islet in norrnoglycaemic Acomys.
An abrupt increase in the concentration of perifusate glucose from 3.3 to 16.7 mmol/1 resulted in a slow insulin response in Acomys islets, devoid of the typical first-phase dynamics (Fig. 1) .
Normoglycaemic Acomys islets resembled islets of hyperglycaemic Acornys dynamics regarding insulin release, with the exception of lower basal secretion rates in the latter. For comparison, the normal dynamics of pressed as the ratio of the amount of insulin released during the initial 6 rain of the second period of stimulation over that found during the initial 6 min period of priming with glucose (16.7 mmol/1). Each point represents four to eight observations. Mean _+ SEM is shown insulin release from isolated rat islets are presented in Figure 1 . An abrupt change in perifusate glucose concentration from 3.3 to 16.7 mmol/1 resulted in an immediate response in rat islets with a typical frist-phase peak within 2-3 rain, followed by a nadir in the release rate at 5-6 min, and a prompt rise to a second phase of insulin secretion thereafter.
Following the first 30-min period of stimulation with high glucose, the perifusate glucose concentration was reduced to 3.3 mmol/1 for 10 min, allowing the insulin secretion rates to return towards baseline. When stimulated a second time with glucose (16.7 mmol/l), insulin secretion from both normoglycaemic and hyperglycaemic Acomys islets was strongly amplified: the sluggish early rate of insulin release seen during the initial stimulus was markedly accelerated during the second stimulus (Fig.l) . Although the peak insulin response was still somewhat delayed in comparison with that of rat islets, the diabetic pattern of secretion was markedly improved. The effect of glucose priming on late insulin release was smaller but significant when calculated over the final 24 min of stimulation (2.4-fold increase in hyperglycaemic Aeomys and 2.2-fold in normoglycaemic Acomys islets).
The time characteristics of the potentiating state induced by the glucose priming were investigated in islets from hyperglycaemic Acomys: two 30-min glucose stimuli 06.7 mmol/1) were applied separated by a basal perifusion (glucose 3.3 mmol/1), the duration of which varied. The degree of potentiation was expressed as the ratio of the second insulin response to the first. Maximal potentiation of both early and late insulin responses was obtained when the time interval between stimuli was 10 min (Fig.2) . With increasing time, the magnitude of the potentiation induced by the glucose priming decreased exponentially, the half-life of the effect both on early and late insulin release being around 18 min.
A full 30-min stimulation was not necessary to generate the priming effect of glucose. Even a 5-min glucose priming was sufficient to double the early insulin response during a second stimulus given 10min later (Fig. 3) . Under these conditions, a maximally potentiating effect was observed following priming with glucose for 20 min.
Discussion
This study deals with the dynamics of insulin secretion in a rodent with predisposition to mild, non-ketotic hyperglycaemia [9] . Except for a slight difference in the basal insulin secretion rate, both the kinetics and the magnitudes of the insulin responses to glucose were comparable whether islets were obtained from hyperglycaemic or from normoglycaemic Aeomys, and the sluggishness and reduced amplitude of the response resembled findings in vivo in patients with Type 2 diabetes [2] [3] [4] [5] [6] [7] . We have previously described low and sluggish insulin responses in some normoglycaemic human subjects, who on prospective study were shown to develop glucose intolerance with a high incidence [24, 25] . The present findings suggest that a similar situation may exist in Acomys cahirinus. It was indeed shown in a previous study [16] that when insulin resistance was in-235 duced in Acomys by dietary measures, the insulin secretion of the animals was not substantially augmented, and consequently hyperglycaemia developed. Thus, the normoglycaemic Aeomys, whose islets have sluggish insulin response to glucose, may represent a model for prediabetes, namely individuals with increased risk of developing diabetes.
The facts that the diabetic-type kinetics of the insulin response can be demonstrated in Aeomys in vivo as well as in vitro, and that there is an excellent correlation between the insulin response of individual animals in vivo and the insulin secretion rates in vitro of the islets isolated from the same animals [12] , indicate that the deranged insulin secretion is an inherent characteristic of the islet of Langerhans in this species. It has been suggested that an anatomical defect might be responsible for the deficient insulin release in Aeomys [8] . The present study clearly indicates that the defect must be of a functional nature, since priming of the islets with glucose in vitro rapidly restored almost normal secretion dynamics.
As shown in this study and in previous reports [17-22, 26, 27] , glucose priming induces in normal islets a time-dependent potentiating memory, which amplifies the insulin response to subsequent stimuli. The nature of the intracellular message generated by the glucose priming is unknown. The time-course studies presented here show that the effect of glucose priming has a fairly long half-life 08 min) and thus contrasts sharply with the rapid disappearance of the acute insulin stimulatory effect of glucose when the hexose is withdrawn. Studies in man [19, 27] , and in vitro using the perfused rat pancreas [20, 21] , have shown that inhibition of the insulin response to glucose during priming does not prevent the generation of a time-dependent potentiation. The present findings support our earlier conclusion [20] that the effects of glucose on acute insulin release and on generation of a potentiating state in the islet are distinct and separable. Thus, while the stimulus-secretion coupling of glucose-induced acute insulin release is defective in the islets of spiny mice, the mechanism responsible for time-dependent potentiation is not impaired.
One important conclusion from this study, as well as from earlier studies in mildly diabetic man [28] , is that the defective stimulus-secretion coupling in a diabetic islet can be corrected: the mechanism of glucose-induced time-dependent potentiation can bypass the block in insulin secretion. If this potentiation operates also in vivo, it may serve as a compensatory mechanism and reduce the severity of the insulin deficit (hence of the hyperglycaemia). That this assumption may be correct is suggested by the finding of a normal glucose-induced potentiation in mild human diabetes, but not in more severe hyperglycaemia [1] .
Analogies between human diabetes and any animal model of the disease call for caution. Nevertheless, the numerous similarities between mild non-insulin depen-dent diabetes and patients with low insulin response on the one hand, and hyperglycaemic and normoglycaemic Aeomys on the other hand, make the spiny mouse a most attractive model for use in investigating some of the biochemical events in the islet that lead to the development of diabetes.
